Deoxy-ribonucleic acid repair genes XRCC1 and XPD polymorphisms and brain tumor risk

Neurosciences

Volumn 13, Issue 3, 2008, Pages 227-232

  Cengiz, Sahika L ^a   Acar, Hasan ^a   Inan, Ziyaeddin ^a   Yavuz, Servet ^a   Baysefer, Alper ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLIOMA; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; RISK FACTOR; TURKEY (REPUBLIC);

EID: 47749119158     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Perera FP, Weinstein IB. Molecular epidemiology: recent advances and future directions. Carcinogenesis 2000; 21: 517-524.
2. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005; 109: 93-108.
3. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002; 4: 278-299.
4. Knudsen LE, Loft SH, Autrup H. Risk assessment: the importance of genetic polymorphisms in man. Mutat Res 2000; 482: 83-88.
5. Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, et al. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 2004; 64: 5560-5563.
6. Casse C, Hu YC, Ahrendt SA. The XRCC1 codon 399 Gln allele is associated with adenine to guanine p53 mutations in non-small cell lung cancer. Mutat Res 2003; 528: 19-27.
7. Erdal N, Erdal ME, Savasoglu K, Gökdogan T. Arg194Trp and Arg399Gln polymorphisms of the DNA repair gene X-ray repair cross-complementing. J Med Sci 2004; 24: 573-578.
8. Canalle R, da Silva S Andrade V, Scrideli CA, de Paula Queiroz RG, Tone LG. Polymorphisms in the thymidylate synthase promoter and the DNA repair genes XRCC1 and XPD in a Brazilian population. Environ Mol Mutagen 2006; 47: 725-732.
9. de las Peñas R, Sanchez-Ronco M, Alberola V, Taron M, Camps C, Garcia-Carbonero R, et al. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol 2006; 7: 668-675.
10. Kocabas NA, Karahalil B. XRCC1Arg399Gln genetic polymorphism in a Turkish population. Int J Toxicol 2006; 25: 419-422.
11. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1513-1530.
12. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 359-365.
13. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomark Prev 2001; 10: 125-131.
14. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer; the role of DNA damage and repair. Cancer Epidemiol Biomark Prev 2003; 12: 689-698.
15. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 359-365.
16. Lee SG, Kim B, Choi J, Kim C, Lee I, Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett 2002; 187: 53-60.
17. Nelson HH, Kelsey KT, Mott LA, Karagas MR. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 2002; 62: 152-155.
18. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 2000; 21: 551-555.
19. Shao J, Gu M, Xu Z, Hu Q, Qian L. Polymorphisms of the DNA gene XPD and risk of bladder cancer in a Southeastern Chinese population. Cancer Genet Cytogenet 2007; 177: 30-36.
20. Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 23-29.
21. Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 2001; 22: 403-408.
22. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 2002; 17: 463-469.
23. Xing D, Tan W, Wei Q, Lin D. Polymorphisms of the DNA repair gene XPD, risk of lung cancer in a Chinese population. Lung Cancer 2002; 38: 123-129.
24. Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, et al. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res 2005; 6: 987-997.
25. Försti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep 2004; 11: 917-922.
26. Mort R, Mo L, McEwan C, Melton DW. Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 2003; 89: 333-337.
27. Yeh CC, Sung FC, Tang R, Chang-Chieh C, Hsieh LL. Polymorphisms of the XRCC1, XRCC3 and XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 2005; 5: 12.